BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Proteomics offers huge advantages for the discovery and pre-cl
 inical development of small molecule drugs and their translation into rob
 ust clinical candidates. Just this year\, Sanofi has dedicated $700M to B
 elharra Therapeutics to develop a proteomics platform and Galapagos has p
 artnered with Bridgene Bio to combine chemoproteomics with computational 
 tools.\n\nThis is the time to harness the power of proteomics to accelera
 te your drug development process and de-risk your pipeline.\n\nThe Inaugu
 ral Proteomics-Based Drug Discovery Summit comes to Boston as the first i
 ndustry dedicated event to help solve bottlenecks across your drug develo
 pment chain including hit screening\, target validation\, hit to lead pro
 gression and in vivo translation to leverage the power of the proteome an
 d drug the "undruggable".\n\nIn 2025\, make sure you join experts where y
 ou will hear exclusive data revealed\, towards supercharging your experim
 ents for screening compound libraries\, unravelling the mechanism of acti
 on\, deconvoluting protein-protein interactions and determining drug pote
 ncy to gear your proteomics platforms for faster development of more effe
 ctive drugs to change patient lives.\n\nURLs:\nWebsite: https://go.evvnt.
 com/2674449-0?pid=185\nTickets: https://go.evvnt.com/2674449-2?pid=185\nB
 rochure: https://go.evvnt.com/2674449-3?pid=185\n\nPrices:\nDrug Develope
 r Pricing - 3 Day Pass (Conference + Workshop Day): USD 4197.00\,\nAcadem
 ic Pricing - 3 Day Pass (Conference + Workshop Day): USD 3597.00\,\nServi
 ce Provider Pricing - 3 Day Pass (Conference + Workshop Day): USD 5097.00
 \,\nDrug Developer Pricing - Conference + 1 Workshop: USD 3598.00\,\nAcad
 emic Pricing - Conference + 1 Workshop: USD 3098.00\,\nService Provider P
 ricing - Conference + 1 Workshop: USD 4398.00\,\nDrug Developer Pricing -
  2 Day Pass (Conference Only): USD 2999.00\,\nAcademic Pricing - 2 Day Pa
 ss (Conference Only): USD 2599.00\,\nService Provider Pricing - 2 Day Pas
 s (Conference Only): USD 3699.00\n\nSpeakers: Alex Campos\, Senior Direct
 or - Systems Biology and Proteomics\, Plexium Inc.\, Bekim Bajrami\, Asso
 ciate Scientific Director\, Biogen\, Chia-Feng Tsai\, Senior Scientist\, 
 Scorpion Therapeutics\, Chris Adams\, Director - Proteomics\, Rezo Therap
 eutics\, Debora Bonenfant\, Vice President\, Head of Proteomics\, Monte R
 osa Therapeutics\, Fiona Pachl\, Associate Principal Scientist - Chemical
  Biology and Proteomics\, AstraZeneca\, Francisco Garcia\, Principal Scie
 ntist\, Novartis AG\, Hai-Tsang (Hubert) Huang\, Research Scientist\, Can
 cer Program\, The Broad Institute of MIT and Harvard\, Jagat Adhikari\, A
 ssociate Director - Translational Proteomics\, Covant Therapeutics\, Kath
 erine Donovan\, Director - Managing and Lead Scientist\, Dana-Farber Canc
 er Institute\, Mahmud Hossain\, Senior Scientist - Disease Profiling and 
 Functional Genomics\, Proteomics\, Sanofi\, Michelle Dubuke\, Principal S
 cientist - Chemoproteomics\, HYKU Biosciences\, Ning Deng\, Director - IM
 TAC Discovery\, BridGene Biosciences Inc.\, Praveen Kumar\, Senior Bioinf
 ormatician - Proteomics\, AstraZeneca\, Rhushikesh Kulkarni\, Principal S
 cientist\, Pfizer\, Thao Nguyen\, Proteomics Scientist\, Calico Life Scie
 nces LLC\, Tyler Bechtel\, Chemical Biology and Proteomics Scientist\, Ba
 yer\, Tyzoon Nomanbhoy\, Vice President\, Chemical Biology\, Vicinitas Th
 erapeutics\, Yan Sun\, Scientist II\, Relay Therapeutics\n\nCategory: Con
 ferences | Science\, Health and Medicine | Pharmaceuticals\n\nDate and Ti
 me: 11th February 2025 at 8:30 am to 13th February 2025 at 4:30 pm\n\nVen
 ue details: Wyndham Boston Beacon Hill\, 5 Blossom Street\, Boston\, Mass
 achusetts\, 02114\, United States\n
DTEND:20250213T163000
DTSTAMP:20260512T225915Z
DTSTART:20250211T083000
LOCATION:Wyndham Boston Beacon Hill\, 5\, Blossom Street\, Boston\, Massac
 husetts\, 02114\,
SEQUENCE:0
SUMMARY:Proteomics offers huge advantages for the discovery and pre-clinic
 al development of small molecule drugs and their translation into robust 
 clinical...
UID:9cfc97d8-ee34-4b85-ad5b-fc1192277027
END:VEVENT
END:VCALENDAR